Scott Terrillion
CIK 1706426 · SEC'Y; CHIEF COMPLIANCE & G.C. · last filed 2025-03-04
Scott Terrillion is a SEC'Y; CHIEF COMPLIANCE & G.C. who has filed 29 SEC Form 4 insider transactions across 1 company since 2018. The most recent filing shows the insider sold $776 of CARA on Mar 4, 2025. Across all open-market trades the lifetime net is −$566.7K, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
1
29
-$566.7K
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Tvardi Therapeutics, Inc. (CARA) Delisted | SEC'Y; CHIEF COMPLIANCE & G.C. | 7,190 | $15.96 | $114.8K | -$566.7K | 29 | 2025-03-04 |
Recent Filings
29 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-03-04 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −163 | -$776 | EDGAR |
| 2024-04-09 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,753 | -$2.3K | EDGAR |
| 2024-03-04 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −3,293 | -$2.9K | EDGAR |
| 2024-02-12 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −7,770 | -$4.1K | EDGAR |
| 2024-02-05 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | +13,500 | $0 | EDGAR |
| 2023-06-27 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,483 | -$8.7K | EDGAR |
| 2023-04-06 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,481 | -$12.2K | EDGAR |
| 2023-03-07 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −6,256 | -$60.7K | EDGAR |
| 2023-03-03 | Tvardi Therapeutics, Inc. (CARA) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-12-23 | Tvardi Therapeutics, Inc. (CARA) Delisted | Sell (S) | −2,561 | -$28.9K | EDGAR |